125 related articles for article (PubMed ID: 8103378)
1. The isolated heart-lung preparation in the cat. An in situ model to study the role of the lungs in the disposition of drugs.
Beaufort AM; Wierda JM; Houwertjes MC; Kleef UW; Meijer DK
J Pharmacol Toxicol Methods; 1993 Jun; 29(3):147-56. PubMed ID: 8103378
[TBL] [Abstract][Full Text] [Related]
2. The pulmonary first-pass uptake of five nondepolarizing muscle relaxants in the pig.
Beaufort TM; Proost JH; Houwertjes MC; Roggeveld J; Wierda JM
Anesthesiology; 1999 Feb; 90(2):477-83. PubMed ID: 9952155
[TBL] [Abstract][Full Text] [Related]
3. Quantification of the aminosteroidal non-depolarizing neuromuscular blocking agents rocuronium and vecuronium in plasma with liquid chromatography-tandem mass spectroscopy.
Gutteck-Amsler U; Rentsch KM
Clin Chem; 2000 Sep; 46(9):1413-4. PubMed ID: 10973876
[No Abstract] [Full Text] [Related]
4. A comparison of the pharmacodynamics of rocuronium and vecuronium during halothane anaesthesia.
Booth MG; Marsh B; Bryden FM; Robertson EN; Baird WL
Anaesthesia; 1992 Oct; 47(10):832-4. PubMed ID: 1359803
[TBL] [Abstract][Full Text] [Related]
5. Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.
Kim DW; Joshi GP; White PF; Johnson ER
Anesth Analg; 1996 Oct; 83(4):818-22. PubMed ID: 8831328
[TBL] [Abstract][Full Text] [Related]
6. Effects of vecuronium and rocuronium in antagonistic laryngeal muscles and the anterior tibial muscle in the cat.
Michalek-Sauberer A; Gilly H; Steinbereithner K; Vizi ES
Acta Anaesthesiol Scand; 2000 May; 44(5):503-10. PubMed ID: 10786732
[TBL] [Abstract][Full Text] [Related]
7. Newer neuromuscular blocking agents: how do they compare with established agents?
Sparr HJ; Beaufort TM; Fuchs-Buder T
Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
Cammu G; De Kam PJ; Demeyer I; Decoopman M; Peeters PA; Smeets JM; Foubert L
Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834
[TBL] [Abstract][Full Text] [Related]
9. Risk of recurarization during retransfusion of autologous blood withdrawn after injection of muscle relaxants: a comparison of rocuronium and mivacurium.
Rohling RG; Rentsch KM; Beck-Schimmer B; Fuchs-Buder T
J Clin Anesth; 2003 Mar; 15(2):85-90. PubMed ID: 12719045
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in myorelaxant therapy.
Meakin GH
Paediatr Anaesth; 2001; 11(5):523-31. PubMed ID: 11696115
[No Abstract] [Full Text] [Related]
11. Pharmacokinetic-pharmacodynamic modeling of rocuronium in case of a decreased number of acetylcholine receptors: a study in myasthenic pigs.
De Haes A; Proost JH; De Baets MH; Stassen MH; Houwertjes MC; Wierda JM
Anesthesiology; 2003 Jan; 98(1):133-42. PubMed ID: 12502989
[TBL] [Abstract][Full Text] [Related]
12. A comparison of rocuronium and vecuronium: the pharmacodynamic, cardiovascular and intra-ocular effects.
Robertson EN; Hull JM; Verbeek AM; Booij LH
Eur J Anaesthesiol Suppl; 1994; 9():116-21. PubMed ID: 7925202
[TBL] [Abstract][Full Text] [Related]
13. The neuromuscular blocking effects and pharmacokinetics of ORG 9426 and ORG 9616 in the cat.
Khuenl-Brady K; Castagnoli KP; Canfell PC; Caldwell JE; Agoston S; Miller RD
Anesthesiology; 1990 Apr; 72(4):669-74. PubMed ID: 1969717
[TBL] [Abstract][Full Text] [Related]
14. Calculation of an effect compartment rate constant using recovery indices obtained with an isolated arm technique.
Shanks CA; Avram MJ; Krejcie TC; Henthorn TK
Br J Anaesth; 1995 Jul; 75(1):109-12. PubMed ID: 7669449
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics and pharmacokinetics of an infusion of Org 9487, a new short-acting steroidal neuromuscular blocking agent.
van den Broek L; Wierda JM; Smeulers NJ; Proost JH
Br J Anaesth; 1994 Sep; 73(3):331-5. PubMed ID: 7946859
[TBL] [Abstract][Full Text] [Related]
16. Influence of chronic phenytoin administration on the pharmacokinetics and pharmacodynamics of vecuronium.
Wright PM; McCarthy G; Szenohradszky J; Sharma ML; Caldwell JE
Anesthesiology; 2004 Mar; 100(3):626-33. PubMed ID: 15108978
[TBL] [Abstract][Full Text] [Related]
17. Precurarization and priming: a theoretical analysis of safety and timing.
Kopman AF; Khan NA; Neuman GG
Anesth Analg; 2001 Nov; 93(5):1253-6. PubMed ID: 11682407
[TBL] [Abstract][Full Text] [Related]
18. Accelerated recovery and disposition from rocuronium in an end-stage renal failure patient on chronic anticonvulsant therapy with sodium valproate and primidone.
Driessen JJ; Robertson EN; Booij LH; Vree TB
Br J Anaesth; 1998 Mar; 80(3):386-8. PubMed ID: 9623443
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of rocuronium bromide in hepatic cirrhosis.
Hunter JM
Eur J Anaesthesiol Suppl; 1995 Sep; 11():39-41. PubMed ID: 8557004
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous or neostigmine-induced recovery after maintenance of neuromuscular block with Org 9487 (rapacuronium) or rocuronium following an initial dose of Org 9487.
McCourt KC; Mirakhur RK; Lowry DW; Carroll MT; Sparr HJ
Br J Anaesth; 1999 May; 82(5):755-6. PubMed ID: 10536556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
